QUEST LABORATORIES LTD Share Price

Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.As of 25 Jun 2026, QUEST LABORATORIES LTD share price is ₹99.60. The stock opened at ₹104.50, compared to its previous close of ₹101.75. During today's trading session, QUEST LABORATORIES LTD share price moved in the range of ₹99.10 to ₹104.50, with an average price of ₹101.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹99.10 and a high of ₹104.50. On the performance front, QUEST LABORATORIES LTD share price has increased by 2.05% over the last six months and is up 14.48% on a year-on-year basis.

The market capitalization of QUEST LABORATORIES LTD is ₹167 Crs, with a P/E ratio of 11.1 and a dividend yield of 0.00%.